Xi Ai is a seasoned scientist with extensive experience in biochemistry and pharmacology. At Merck from October 2012 to May 2020, Xi Ai held positions as Principal Scientist and Associate Principal Scientist, focusing on screening and compound profiling, as well as acting as the In Vitro Pharmacology representative for TIDV programs. Prior to Merck, Xi Ai worked as a post-doctoral researcher at Princeton University and The Ohio State University, contributing to significant studies on eukaryotic helicases, histone acetylation, and chromatin assembly. Educational credentials include a Ph.D. in Biochemistry from The Ohio State University and an M.S. in Biochemistry and Biophysics from the Institute of Biophysics, Academy of Chinese Sciences. Early research experience includes a graduate research associate role in insulin crystallography and a research assistantship focused on monoclonal antibody development.
This person is not in any teams
This person is not in any offices